Pedersen Lasse, Eriksen Lotte L, Brix Frederik H, Vilstrup Hendrik, Deleuran Bent, Sandahl Thomas D, Støy Sidsel
Department of Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus, Denmark.
Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
J Clin Exp Hepatol. 2025 Jan-Feb;15(1):102424. doi: 10.1016/j.jceh.2024.102424. Epub 2024 Oct 10.
Alcohol-associated hepatitis (AH) has a short-term mortality rate of up to 40% primarily related to impaired hepatocyte regeneration and uncontrolled liver inflammation. The acute phase protein fibrinogen-like protein 1 (FGL-1) produced by hepatocytes stimulates hepatocyte proliferation by autocrine signaling. FGL-1 also is a ligand for the inhibitory T cell receptor lymphocyte activation gene 3 (LAG-3). In these ways, FGL-1 and LAG-3 have beneficial interactions that could be interrupted in AH.
We aimed to characterize FGL-1 and LAG-3 in patients with AH and describe their relationship with the disease state and course.
Thirty-two patients with AH were included at diagnosis and followed up for 3 years. We measured the hepatic gene expression of FGL-1 and LAG-3 using RNA sequencing, plasma FGL-1 and soluble (s)LAG-3 using ELISA, and LAG-3CD8 T cells using flow cytometry. Healthy persons (HC) and patients with stable alcohol-associated cirrhosis served as controls.
At diagnosis of AH, liver FGL-1 mRNA was increased when compared to HC, whereas plasma FGL-1 was unchanged. In contrast, liver LAG-3 mRNA was reduced in AH. Plasma sLAG-3 levels and the frequency of LAG-3CD8 T cells were as in HC. However, those patients who had the lowest plasma FGL-1 and the lowest frequency of LAG-3CD8 T cells at diagnosis had the highest disease severity and mortality.
Our data suggest that an impaired FGL-1/LAG-3 axis may be involved in the pathogenesis and course of AH.
酒精性肝炎(AH)的短期死亡率高达40%,主要与肝细胞再生受损和无法控制的肝脏炎症有关。肝细胞产生的急性期蛋白纤维蛋白原样蛋白1(FGL-1)通过自分泌信号刺激肝细胞增殖。FGL-1也是抑制性T细胞受体淋巴细胞激活基因3(LAG-3)的配体。通过这些方式,FGL-1和LAG-3具有有益的相互作用,而这种相互作用在AH中可能会被中断。
我们旨在描述AH患者中FGL-1和LAG-3的特征,并阐述它们与疾病状态和病程的关系。
32例AH患者在诊断时被纳入研究,并随访3年。我们使用RNA测序测量FGL-1和LAG-3的肝脏基因表达,使用酶联免疫吸附测定(ELISA)测量血浆FGL-1和可溶性(s)LAG-3,使用流式细胞术测量LAG-3⁺CD8⁺ T细胞。健康人(HC)和稳定期酒精性肝硬化患者作为对照。
在AH诊断时,与HC相比,肝脏FGL-1 mRNA增加,而血浆FGL-1没有变化。相反,AH患者肝脏LAG-3 mRNA减少。血浆sLAG-3水平和LAG-3⁺CD8⁺ T细胞频率与HC相同。然而,那些在诊断时血浆FGL-1最低且LAG-3⁺CD8⁺ T细胞频率最低的患者疾病严重程度和死亡率最高。
我们的数据表明,FGL-1/LAG-3轴受损可能参与了AH的发病机制和病程。